MNTN, Inc. MNTN 深 滬
已收盤 12-19 16:00:00 美东时间
11.78
+0.060
+0.51%
華盛通- 最 高11.93
- 今 開11.71
- 成交量 52.97万股
- 最 低 11.6201
- 昨 收 11.72
- 總市值 8.63亿
- 52周最高 32.49
- 市盈率 靜 --
- 換手率 0.72%
- 52周最低 11.6201
- 委 比 62.07%
- 總股本 7322.33万
- 歷史最高 32.49
- 量 比 0.91
- 振 幅 2.64%
- 歷史最低 11.6201
- 每 手 1
- 風險率 4.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
12-05 08:35
Canaccord Genuity Initiates Coverage On MNTN with Buy Rating, Announces Price Target of $20
Canaccord Genuity analyst Matthew Weber initiates coverage on MNTN (NYSE:MNTN) with a Buy rating and announces Price Target of $20.
12-04 21:41
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
Needham Maintains Buy on MNTN, Lowers Price Target to $18
Needham analyst Laura Martin maintains MNTN (NYSE:MNTN) with a Buy and lowers the price target from $35 to $18.
11-05 19:51
MNTN Sees Q4 Sales $85.500M-$86.500M vs $85.755M Est
Fourth Quarter 2025 Outlook:Revenues are expected to be between $85.5 million and $86.5 million, representing expected year-over-year growth of 34.0% at the midpoint excluding the impact of the Maximum Effort
11-05 05:24
MNTN Q3 EPS $0.08 Beats $0.06 Estimate, Sales $70.023M Miss $70.101M Estimate
MNTN (NYSE:MNTN) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 by 33.33 percent. This is a 128.57 percent increase over losses of $(0.28) per share from the same period
11-05 05:23
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
美股大行评级 | 升至45美元！英特尔获多家机构上调目标价；大摩上调拖拉机供应公司(TSCO)评级至"标配"，目标价升至60美元
今日重点评级关注：HC Wainwright & Co.：维持Alto Neuroscience"买入"评级，目标价从10美元升至50美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从110美元升至117美元
10-27 09:45
